$PULM 10 bagger corrected $4.68
Website
$PULM 10 bagger corrected $4.68
Website
Harvard Scientist Points to Pulmatrix's Inhaled Drug Delivery
Innovation to Help Fight Lung Disease
ACCESSWIRE via CMTX - Wed Feb 08,
Many Seeking Alpha articles
Last 10 trades
10/Q 11/4/16
O/S 14,701,564 - Ultra low float.
with 148,962 shares of common stock deliverable
on a delayed basis pursuant to restricted stock
units that have vested.
news
and filings
Stock technical analysis
88% x 100% Strong buy
Pulmatrix, Inc., a clinical stage biopharmaceutical company, engages in developing inhaled therapies to address serious pulmonary diseases using its inhaled Small Particles Easily Respirable and Emitted (iSPERSE) technology. The companys proprietary product pipeline focuses on advancing treatments for rare diseases, including PUR1900, an inhaled anti-fungal for patients with cystic fibrosis, as well as PUR1500, an inhaled product for the treatment of idiopathic pulmonary fibrosis. It is also developing PUR0200, a branded generic in clinical development for chronic obstructive pulmonary disease. The company has collaboration with Capsugel to develop inhaled therapeutics to treat serious pulmonary diseases. Pulmatrix, Inc. was founded in 2003 and is headquartered in Lexington, Massachusetts.
Pulmatrix, Inc. (PULM) Stock Research Links
Featured stocks: Coffee Shoppe
For conservative debate: "Keeping it Real"
Game Changing stock $SHMP
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Trouble Is Brewing for Hims & Hers Investors This isn't your typical quiet stroll through the park when it comes to Hims & Hers Health, Inc. (NYSE: HIMS). We're talking about a full-blown legal showdown that's unfolding faster than you can say 'telehealth scandal.' October 25, 2026, saw the kind of announcement that makes seasoned investors' hearts skip a beat if they've...
Continue Reading
Massive Settlement: A Long-Awaited Justice Here's a different kind of news that's hitting like a thunderbolt. Over 1,300 survivors of abuse have finally struck a landmark deal with the Archdiocese of New York. Not only are the numbers staggering, but the relief for these individuals is palpable. We're talking about more than $800 million on the table here. That's some...
Continue Reading
Unexpected Turn of Events at Sea Now here's a gut-punch nobody saw coming. Borr Drilling Limited (NYSE and OSE: BORR) got hit hard when their Prospector 5 drilling rig went under the waves offshore Gabon. This ain't no desk job dilemma; we're talking about a real-life offshore catastrophe. It all went down on October 24, 2026, when the rig experienced a punch through...
Continue Reading
Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...
Continue Reading
Ping An's Pitch for Green: Talking the Talk and Walking the Walk? Well, here's something cooking in Shenzhen at the Ping An Finance Center—an international seminar championing green development initiatives. It's all buzz around Ping An Insurance (HKEX: 2318; SSE: 601318) flexing its green muscle, orchestrating conversations right before APEC 2026. Talk about timing....
Continue Reading
LexisNexis Takes a Serious Step Forward The world of law enforcement reporting just got a shake-up. LexisNexis Coplogic Solutions launched a souped-up version of its Desk Officer Reporting System (DORS) at the IACP 2026 event. They paired DORS with Field Clarity, a newfangled AI-powered assistant that aims to make police reporting slicker and more accurate. You can bet...
Continue Reading
Impressive Outcomes for RYBREVANT FASPRO in Head and Neck Cancer Tucked away in the endless cycle of drug trials, a glimmer of hope shines through with new data on RYBREVANT FASPRO in treating head and neck squamous cell carcinoma (HNSCC). This science talk might not rattle the ticker tape directly on NYSE:JNJ, but it has all the makings of a game-changer in the oncology...
Continue Reading
A Festive Transformation at CARNE Rolling into Oxnard, you're met with an unconventional dining spectacle at CARNE. It's not your average restaurant fare as they've pulled out the stops with their spirited Halloween pop-up, A Nightmare at CARNE. Channeling the eerie charm of "The Nightmare Before Christmas," this temporary transformation morphs the venue into a lively,...
Continue Reading
Kicking Off Early Black Friday with Dash Cam Bargains In a bid to stay ahead of the holiday shopping rush, Vantrue announced its early Black Friday campaign with a range of discounts designed to capture the interest of road warriors and casual drivers alike. From November 1 to November 21, 2026, Vantrue is inviting bargain hunters to explore their offerings—culminating...
Continue Reading
In today's fast-paced digital world, small businesses lament the constant hustle to stay relevant online. This juggling act with limited resources often makes effective marketing feel like a high-wire circus performance. Enter AI tools, promising to lighten the load, and CapCut stands out as a game-changer. AI Tools Revolutionizing Small Business Marketing Amid growing...
Continue Reading
Top 5 Most Recently Viewed Articles
Paycor HCM, Inc. Financial Performance Overview Paycor HCM, Inc. (Nasdaq: PYCR) has released its financial results for the first quarter of fiscal year 2025, marking a remarkable performance period. With total revenues reaching $167.5 million, reflecting a robust increase of 17% compared to the prior year, Paycor has established itself as a leader in human capital...
Continue Reading
Nuvia Dental Implant Centers' Innovative Dental Solutions Nuvia Dental Implant Centers is a recognized leader in advanced dental implant solutions. The center is making waves in the dental community with its revolutionary approach to dental implants, delivering permanent teeth in just 24 hours. Recently, Nuvia's impressive capabilities were highlighted in a segment...
Continue Reading
Textron Inc. Experiences a Dip in Q4 Earnings Textron Inc. recently revealed its Q4 financial results, which fell short of what analysts had anticipated. As a consequence, shares dropped by 1.5% in early trading. This aerospace and defense titan reported adjusted earnings per share of $1.34, a slight miss compared to the consensus estimate of $1.35. Furthermore, the...
Continue Reading
Introduction to Vivici's Innovation Vivici, a dynamic Dutch ingredients startup, is redefining the landscape of protein ingredients with the introduction of its innovative Vivitein™ BLG in the US market. This cutting-edge product not only serves as a dairy protein but also utilizes precision fermentation, marking a significant breakthrough in functional and nutritional...
Continue Reading
Understanding the Solid-state LiDAR Market Dynamics The market for solid-state LiDAR technology is rapidly evolving, and it holds a promising future. As industries increasingly recognize the advantages of solid-state LiDAR systems, the market is projected to reach a valuation of USD 3.20 billion by 2030, a substantial increase from USD 0.50 billion in 2025. This...
Continue Reading